Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

893 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterizing the Clinical Trajectory and Predicting Persistence and Deterioration of Attenuated Psychotic Symptoms in Ultra-High-Risk Individuals.
Wannan C, Scott I, Dwyer D, Clark SR, Hartmann S, Ye RR, Amminger GP, Yuen HP, Lavoie S, Markulev C, Schaefer MR, Hartmann JA, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Kerr M, Spark J, Wallis N, Polari A, McGorry PD, Nelson B. Wannan C, et al. Among authors: nordentoft m. Schizophr Bull. 2024 Dec 20:sbae204. doi: 10.1093/schbul/sbae204. Online ahead of print. Schizophr Bull. 2024. PMID: 39707153
Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study.
Byrne JF, Healy C, Föcking M, Susai SR, Mongan D, Wynne K, Kodosaki E, Heurich M, de Haan L, Hickie IB, Smesny S, Thompson A, Markulev C, Young AR, Schäfer MR, Riecher-Rössler A, Mossaheb N, Berger G, Schlögelhofer M, Nordentoft M, Chen EYH, Verma S, Nieman DH, Woods SW, Cornblatt BA, Stone WS, Mathalon DH, Bearden CE, Cadenhead KS, Addington J, Walker EF, Cannon TD, Cannon M, McGorry P, Amminger P, Cagney G, Nelson B, Jeffries C, Perkins D, Cotter DR. Byrne JF, et al. Among authors: nordentoft m. Schizophr Bull. 2024 Apr 30;50(3):579-588. doi: 10.1093/schbul/sbad184. Schizophr Bull. 2024. PMID: 38243809 Free PMC article.
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.
Wannan CMJ, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker JT, Bearden CE, Billah T, Bouix S, Broome MR, Buccilli K, Cadenhead KS, Calkins ME, Cannon TD, Cecci G, Chen EYH, Cho KIK, Choi J, Clark SR, Coleman MJ, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Dwyer D, Ebdrup BH, Ellman LM, Fusar-Poli P, Galindo L, Gaspar PA, Gerber C, Glenthøj LB, Glynn R, Harms MP, Horton LE, Kahn RS, Kambeitz J, Kambeitz-Ilankovic L, Kane JM, Kapur T, Keshavan MS, Kim SW, Koutsouleris N, Kubicki M, Kwon JS, Langbein K, Lewandowski KE, Light GA, Mamah D, Marcy PJ, Mathalon DH, McGorry PD, Mittal VA, Nordentoft M, Nunez A, Pasternak O, Pearlson GD, Perez J, Perkins DO, Powers AR 3rd, Roalf DR, Sabb FW, Schiffman J, Shah JL, Smesny S, Spark J, Stone WS, Strauss GP, Tamayo Z, Torous J, Upthegrove R, Vangel M, Verma S, Wang J, Rossum IW, Wolf DH, Wolff P, Wood SJ, Yung AR, Agurto C, Alvarez-Jimenez M, Amminger P, Armando M, Asgari-Targhi A, Cahill J, Carrión RE, Castro E, Cetin-Karayumak S, Mallar Chakravarty M, Cho YT, Cotter D, D'Alfonso S, Ennis M, Fadnavis S, Fonteneau C, Gao C, Gupta T, Gur RE, Gur RC, Hamilton HK, Hoftman GD, Jacobs GR, Jarcho J, Ji JL, Kohler CG, Lalo… See abstract for full author list ➔ Wannan CMJ, et al. Among authors: nordentoft m. Schizophr Bull. 2024 Apr 30;50(3):496-512. doi: 10.1093/schbul/sbae011. Schizophr Bull. 2024. PMID: 38451304 Free PMC article.
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention Trial.
Nelson B, Yuen HP, Amminger GP, Berger G, Chen EYH, de Haan L, Hartmann JA, Hickie IB, Lavoie S, Markulev C, Mossaheb N, Nieman DH, Nordentoft M, Polari A, Riecher-Rössler A, Schäfer MR, Schlögelhofer M, Smesny S, Tedja A, Thompson A, Verma S, Yung AR, McGorry PD. Nelson B, et al. Among authors: nordentoft m. Schizophr Bull Open. 2020 Mar 2;3(1):sgaa006. doi: 10.1093/schizbullopen/sgaa006. eCollection 2022 Jan. Schizophr Bull Open. 2020. PMID: 39144772 Free PMC article.
Twelve-Month Cognitive Trajectories in Individuals at Ultra-High Risk for Psychosis: A Latent Class Analysis.
Allott K, Schmidt SJ, Yuen HP, Wood SJ, Nelson B, Markulev C, Lavoie S, Brewer WJ, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Amminger P, McGorry PD, Hartmann J. Allott K, et al. Among authors: nordentoft m. Schizophr Bull Open. 2022 Jan 13;3(1):sgac008. doi: 10.1093/schizbullopen/sgac008. eCollection 2022 Jan. Schizophr Bull Open. 2022. PMID: 39144786 Free PMC article.
Development and temporal validation of a clinical prediction model of transition to psychosis in individuals at ultra-high risk in the UHR 1000+ cohort.
Hartmann S, Dwyer D, Cavve B, Byrne EM, Scott I, Gao C, Wannan C, Yuen HP, Hartmann J, Lin A, Wood SJ, Wigman JTW, Middeldorp CM, Thompson A, Amminger P, Schlögelhofer M, Riecher-Rössler A, Chen EYH, Hickie IB, Phillips LJ, Schäfer MR, Mossaheb N, Smesny S, Berger G, de Haan L, Nordentoft M, Verma S, Nieman DH, McGorry PD, Yung AR, Clark SR, Nelson B. Hartmann S, et al. Among authors: nordentoft m. World Psychiatry. 2024 Oct;23(3):400-410. doi: 10.1002/wps.21240. World Psychiatry. 2024. PMID: 39279417 Free PMC article.
Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis.
Susai SR, Healy C, Mongan D, Heurich M, Byrne JF, Cannon M, Cagney G, Wynne K, Markulev C, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Street R, Thompson A, Yung AR, Nelson B, McGorry PD, Föcking M, Amminger GP, Cotter D. Susai SR, et al. Among authors: nordentoft m. Transl Psychiatry. 2022 Oct 28;12(1):454. doi: 10.1038/s41398-022-02217-0. Transl Psychiatry. 2022. PMID: 36307392 Free PMC article.
Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical Outcome.
Hird EJ, Ohmuro N, Allen P, Moseley P, Kempton MJ, Modinos G, Sachs G, van der Gaag M, de Haan L, Gadelha A, Bressan R, Barrantes-Vidal N, Ruhrmann S, Catalan A; EU-GEI High Risk Study; McGuire P. Hird EJ, et al. Schizophr Bull. 2023 Mar 15;49(2):339-349. doi: 10.1093/schbul/sbac163. Schizophr Bull. 2023. PMID: 36516396 Free PMC article.
Influence of cannabis use on incidence of psychosis in people at clinical high risk.
Chester LA, Valmaggia LR, Kempton MJ, Chesney E, Oliver D, Hedges EP, Klatsa E, Stahl D, van der Gaag M, de Haan L, Nelson B, McGorry P, Amminger GP, Riecher-Rössler A, Studerus E, Bressan R, Barrantes-Vidal N, Krebs MO, Glenthøj B, Nordentoft M, Ruhrmann S, Sachs G, McGuire P; EU-GEI High Risk Study Group. Chester LA, et al. Among authors: nordentoft m. Psychiatry Clin Neurosci. 2023 Sep;77(9):469-477. doi: 10.1111/pcn.13555. Epub 2023 May 13. Psychiatry Clin Neurosci. 2023. PMID: 37070555 Free PMC article.
Impact of adverse childhood experiences on educational achievements in young people at clinical high risk of developing psychosis.
Tognin S, Catalan A, Kempton MJ, Nelson B, McGorry P, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs MO, Nordentoft M, Ruhrmann S, Sachs G, Rutten BPF, van Os J, de Haan L, van der Gaag M; EU-GEI High-Risk Study; McGuire P, Valmaggia LR. Tognin S, et al. Among authors: nordentoft m. Eur Psychiatry. 2023 Jan 18;66(1):e16. doi: 10.1192/j.eurpsy.2022.2351. Eur Psychiatry. 2023. PMID: 36649929 Free PMC article.
893 results